Goldman likes McKesson in premarket analyst action

11:53am, Wednesday, 18'th Mar 2020
Osmotica Pharmaceuticals (NASDAQ:OSMT) initiated with Buy rating and $8 (74% upside) price target at SunTrust.Epizyme (NASDAQ:EPZM) added to Best Ideas List at Wedbush with a $30 (68% upside) price ta
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
AbbVie, Gilead Sciences, and Pfizer should help immunize your portfolio against the ravages of the coronavirus.

7 Biotech Stocks to Buy and Hold in 2020

02:31pm, Monday, 16'th Mar 2020
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published this article and predicted that US stocks will go down by at least 20% in the next 3-6

Best & Worst ADRS - Monday, March 9

05:22pm, Monday, 09'th Mar 2020
The top-ranked sectors are utilities and technology. Healthcare, consumer goods, and basic materials rank neutral.
The long term is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
When Novartis signed on as a partner to Pliant Therapeutics last fall, it also agreed to eventually take an equity stake in the smaller biotech. The Swiss
Galapagos was down on a ratings downgrade. Insmed misses Q4 EPS. Perrigo gets an approval.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG), Allergan (AGN) and Puma Biotechnology
Not all high-priced stocks have earned their valuations. But these seven stocks to buy are great despite their price tags.
Hutchison China MediTech (NASDAQ:HCM) initiated with Buy rating and $38 (38% upside) price target at Goldman Sachs.Eidos Therapeutics (NASDAQ:EIDX) initiated with Buy rating and $66 (27% upside) price
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE